Ajooni Biotech Q1 FY27 revenue doubles YoY but profit drops

Revenue Growth 20pctResults View source PDF Explain this filing

AJOONI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.1%Reaction day

₹3.89

prior close

₹3.86

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-2.2% vs market

Animal Feed peers, median of 6sector+0.8%-2.9% vs sector

On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 2.9 pts less than its Animal Feed peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.3

10m

+0.3

15m

+0.0

30m

-1.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.1+0.1-2.2+0.8-2.9

Next day

-2.3+0.5-2.8+0.9-3.2

-2.6-0.1-2.5-1.1-1.5

-3.6+0.4-4.0-0.3-3.3

-3.9+0.7-4.5-1.4-2.4

-3.9+0.9-4.8-3.6-0.3

+0.3+1.1-0.8-3.0+3.2

15d

-10.0+1.6-11.6+4.4-14.5

-15.7-0.7-14.9-1.1-14.6

-24.7-3.2-21.4-7.4-17.2

—————

UpDownMarket · Nifty Microcap 250Sector · Animal Feed peers, median of 6Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ajooni Biotech posted Q1 FY27 revenue of 6,349 lakhs, up 103 percent from 3,127 lakhs a year ago. However, net profit fell to 43 lakhs from 78 lakhs as finance costs jumped nearly six times to 48 lakhs and raw material costs rose sharply. EPS stood at 0.01 versus 0.02. Current borrowings rose to 2,550 lakhs from 1,622 lakhs.

Likely market impact

Strong revenue growth shows demand pickup, but margin pressure from higher finance costs and falling profit may worry investors.